Padagis Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PADAGIS US
PADAGIS US has ninety-two approved drugs.
There is one US patent protecting PADAGIS US drugs.
There are twenty-two patent family members on PADAGIS US drugs in fourteen countries and one hundred and fifty-one supplementary protection certificates in sixteen countries.
Summary for Padagis Us
| International Patents: | 22 |
| US Patents: | 1 |
| Tradenames: | 68 |
| Ingredients: | 64 |
| NDAs: | 92 |
| PTAB Cases with Padagis Us as petitioner: | See PTAB cases with Padagis Us as petitioner |
Drugs and US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | TOBRAMYCIN AND DEXAMETHASONE | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 212715-001 | Feb 11, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | SULFACETAMIDE SODIUM | sulfacetamide sodium | LOTION;TOPICAL | 078649-001 | Mar 23, 2009 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | HYDROCORTISONE | hydrocortisone | CREAM;TOPICAL | 085025-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | TROSPIUM CHLORIDE | trospium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 201291-001 | May 24, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | 6,299,900 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 5,266,329 | ⤷ Start Trial |
| Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | 6,013,657 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 4,078,071 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for PADAGIS US drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Vaginal Cream | 2% | ➤ Subscribe | 2015-02-05 |
| ➤ Subscribe | Enteric Coated Capsules | 3 mg | ➤ Subscribe | 2008-02-01 |
International Patents for Padagis Us Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2635992 | ⤷ Start Trial |
| Australia | 2006332519 | ⤷ Start Trial |
| China | 1852690 | ⤷ Start Trial |
| Canada | 2540129 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Padagis Us Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1267866 | 122014000025 | Germany | ⤷ Start Trial | PRODUCT NAME: GLYCOPYRRONIUM ODER EIN SALZ ODER DERIVAT HIERVON (KOMPONENTE 1) UND INDACATEROL ODER EIN DERIVAT HIERVON ODER EIN SALZ VON INDACATEROL ODER EINEM DERIVAT HIERVON (KOMPONENTE 2); REGISTRATION NO/DATE: EU/1/13/862 20130919 |
| 1304992 | CR 2013 00053 | Denmark | ⤷ Start Trial | PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322 |
| 1441735 | 2008/010 | Ireland | ⤷ Start Trial | PRODUCT NAME: RALTEGRAVIR OR A PHARMECEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; NAT AUTHORISTION NO/DATE: EU/1/07/436/001-002 20071220; |
| 0303507 | 64/1997 | Austria | ⤷ Start Trial | PRODUCT NAME: ''NARATRIPTAN'', GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES ODER SOLVATES EINSCHLIESSLICH DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: 1-22059 19970731; FIRST REGISTRATION: SE 13382 19970310 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.

